Drug:
Reaction: ECZEMA
20250101 - 20251231
No. 1 - 100
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 1 | 25138816 |
US |
58 | 2 |
Eczema, Eye irritation, Eye pruritus, Intentional dose omission, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 2 | 25138817 |
US |
30 | 1 |
Eczema, Pruritus, Dry skin, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 3 | 25138840 |
US |
15 | 2 |
Eczema, Pruritus, Dry skin, Skin exfoliation, |
||||
DUPILUMAB, |
||||
| 4 | 25139005 |
GB |
15 | 1 |
Inflammation, Erythema, Eczema, Eczema, Pruritus, |
||||
TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, |
||||
| 5 | 25139061 |
US |
4 | 1 |
Eczema, Rash, Pruritus, |
||||
DUPILUMAB, |
||||
| 6 | 25139571 |
US |
2 | |
Eczema, Hypersensitivity, Abnormal behaviour, |
||||
TROFINETIDE, |
||||
| 7 | 25141519 |
US |
42 | 1 |
Eczema, Drug ineffective, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 8 | 25141566 |
US |
40 | 2 |
Eczema, |
||||
DUPILUMAB, |
||||
| 9 | 25141585 |
US |
32 | 2 |
Eczema, Pruritus, Haemorrhage, |
||||
DUPILUMAB, BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, DAPAGLIFLOZIN, MOMETASONE, FLUOCINOLONE ACETONIDE OIL, FLUOCINOLONE ACETONIDE, KETOCONAZOLE, KETOCONAZOLE FOAM, KETOCONAZOLE CREAM, 2%, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, FLUCONAZOLE, BREXPIPRAZOLE, ALBUTEROL SULFATE, FLUTICASONE PROPIONATE AND SALMETEROL, |
||||
| 10 | 25141591 |
US |
54 | 1 |
Eczema, Pruritus, |
||||
DUPILUMAB, |
||||
| 11 | 25141600 |
US |
54 | 2 |
Eczema, Inflammation, Swelling face, Injection site pain, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 12 | 25141642 |
US |
69 | 2 |
Periorbital discomfort, Eczema, Rash pruritic, Injection site pain, Product preparation error, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 13 | 25141645 |
US |
33 | 2 |
Eczema, Pruritus, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 14 | 25141670 |
US |
1 | |
Eczema, Rash, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 15 | 25141774 |
US |
59 | 2 |
Stress, Eczema, |
||||
NALTREXONE, DUPILUMAB, |
||||
| 16 | 25141867 |
US |
26 | 1 |
Eczema, |
||||
DUPILUMAB, |
||||
| 17 | 25142114 |
US |
31 | 2 |
Eczema, |
||||
DUPILUMAB, |
||||
| 18 | 25142158 |
CA |
53 | 1 |
Bronchiectasis, Deep vein thrombosis, Haematochezia, Pulmonary embolism, Rectal haemorrhage, Tubulointerstitial nephritis, Cerebrovascular accident, Adverse drug reaction, Burns second degree, Cardiac murmur, Catarrh, Confusional state, Depression, Steroid dependence, Parosmia, Dysgeusia, Arthritis, Swollen tongue, Gingival pain, Stress, Hypopnoea, Tinnitus, Weight decreased, Impaired quality of life, Impaired work ability, Loss of personal independence in daily activities, Migraine, Nightmare, Somnolence, Vertigo, Eczema, Palpitations, Abdominal discomfort, Pain, Systemic lupus erythematosus, Pyrexia, Colitis ulcerative, Pain in extremity, Frequent bowel movements, Rash, Rhinitis, COVID-19, Fatigue, Headache, Condition aggravated, Drug ineffective, Medication error, Off label use, Inappropriate schedule of product administration, Intentional product use issue, Product use in unapproved indication, Accidental overdose, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ALBENDAZOLE, ALBENDAZOLE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, DAPAGLIFLOZIN, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, FELODIPINE, FELODIPINE EXTENDED-RELEASE TABLETS, FUROSEMIDE, GABAPENTIN, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OXYCODONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, ROSUVASTATIN, ROSUVASTATIN, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, ERGOCALCIFEROL, WARFARIN SODIUM, WARFARIN, WARFARIN SODIUM, WARFARIN, WARFARIN SODIUM, WARFARIN, WARFARIN SODIUM, WARFARIN, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, CANDESARTAN, LISDEXAMFETAMINE DIMESYLATE, LISDEXAMFETAMINE, LISDEXAMFETAMINE DIMESYLATE CAPSULES, WARFARIN SODIUM, WARFARIN, WARFARIN SODIUM, WARFARIN, WARFARIN, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, MESALAMINE, VEDOLIZUMAB, VEDOLIZUMAB, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, EPINEPHRINE, ADRENALINUM, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, LISDEXAMFETAMINE DIMESYLATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CANDESARTAN CILEXETIL, ROSUVASTATIN, ROSUVASTATIN, ROSUVASTATIN, LEVOTHYROXINE, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, LISDEXAMFETAMINE DIMESYLATE, LISDEXAMFETAMINE, LISDEXAMFETAMINE DIMESYLATE CAPSULES, OXYCODONE HYDROCHLORIDE, OXYCODONE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, AMLODIPINE BESYLATE, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, DORZOLAMIDE HYDROCHLORIDE, DORZOLAMIDE, FESOTERODINE FUMARATE, FOLIC ACID, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, LATANOPROST, LATANOPROST, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, RAMIPRIL, RIVAROXABAN, TAMSULOSIN HYDROCHLORIDE, TOFACITINIB, TOFACITINIB, MINERAL OIL, NITROFURANTOIN, NITROFURANTOIN MONOHYDRATE/MACROCRYSTALS, NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS), TETRAHYDROZOLINE HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, LANSOPRAZOLE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, EMPAGLIFLOZIN, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, DORZOLAMIDE, PREGABALIN, MINERAL OIL, NAPHAZOLINE HYDROCHLORIDE, AMLODIPINE, AMLODIPINE, TETRAHYDROZOLINE HYDROCHLORIDE, |
||||
| 19 | 25142166 |
US |
39 | 2 |
Eczema, |
||||
DUPILUMAB, |
||||
| 20 | 25142273 |
US |
20 | 1 |
Eczema, Rash erythematous, Skin exfoliation, Rash, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 21 | 25142326 |
US |
2 | |
Eczema, Drug ineffective, |
||||
DUPILUMAB, |
||||
| 22 | 25142730 |
US |
||
Eczema, |
||||
PEGVALIASE-PQPZ, EPINEPHRINE, ADRENALINUM, |
||||
| 23 | 25138165 |
US |
33 | 2 |
Eczema, |
||||
DUPILUMAB, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, |
||||
| 24 | 25138171 |
US |
78 | 2 |
Eczema, |
||||
DUPILUMAB, |
||||
| 25 | 25138242 |
US |
55 | 2 |
Foreign body sensation in eyes, Condition aggravated, Eye swelling, Condition aggravated, Ocular hyperaemia, Condition aggravated, Dry eye, Vision blurred, Condition aggravated, Eye irritation, Condition aggravated, Eye pruritus, Condition aggravated, Eczema, Inappropriate schedule of product administration, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 26 | 25138380 |
US |
76 | 1 |
Eczema, Condition aggravated, |
||||
DUPILUMAB, |
||||
| 27 | 25138434 |
US |
1 | |
Eczema, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 28 | 25138461 |
US |
24 | 1 |
Dermatitis atopic, Eczema, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 29 | 25137307 |
US |
2 | 2 |
Eczema, Pruritus, Scratch, Middle insomnia, |
||||
DUPILUMAB, |
||||
| 30 | 25137325 |
US |
29 | 1 |
Eczema, |
||||
DUPILUMAB, |
||||
| 31 | 25137532 |
CA |
||
Blood pressure increased, Pneumonia, Poor venous access, Blood potassium decreased, Vertigo, Eczema, Ear discomfort, Irritability, Brain fog, Condition aggravated, Muscle spasms, Fatigue, Vision blurred, Off label use, Product dose omission issue, |
||||
RITUXIMAB-ABBS, RITUXIMAB-ABBS, RITUXIMAB-ABBS, RITUXIMAB-ABBS, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PREDNISONE, AVACOPAN, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, SULFAMETHOXAZOLE AND TRIMETHOPRIM, DIPHENHYDRAMINE HYDROCHLORIDE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, |
||||
| 32 | 25137612 |
US |
8 | 1 |
Eczema, |
||||
DUPILUMAB, |
||||
| 33 | 25137725 |
FR |
53 | 2 |
Feeling abnormal, Fatigue, Retinal vein occlusion, Anaemia, Road traffic accident, Fall, Craniocerebral injury, Vertigo, Cervical vertebral fracture, Back disorder, Hand dermatitis, Deafness, Dyspnoea, Dizziness, Chest pain, Inappropriate schedule of product administration, Mouth ulceration, Influenza, Eczema, Fear of falling, Drug intolerance, Tachycardia, Pain in extremity, Fear, Polyuria, Drug ineffective, Dry mouth, Lip injury, Serum ferritin decreased, |
||||
SPIRONOLACTONE, |
||||
| 34 | 25138021 |
US |
25 | 2 |
Rebound eczema, Rash, Eczema, Product dose omission in error, Rash, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 35 | 25138034 |
US |
3 | 1 |
Sensitivity to weather change, Ocular hyperaemia, Eczema, Rash, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 36 | 25132162 |
US |
82 | 1 |
Eczema, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 37 | 25132229 |
GB |
15 | 1 |
Inflammation, Pruritus, Erythema, Eczema, |
||||
TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, |
||||
| 38 | 25133405 |
US |
25 | 2 |
Dermatitis atopic, Therapeutic response decreased, Eczema, |
||||
DUPILUMAB, |
||||
| 39 | 25133911 |
US |
23 | 2 |
Eczema, Rash, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 40 | 25134014 |
US |
40 | 1 |
Eczema, |
||||
DUPILUMAB, |
||||
| 41 | 25134017 |
US |
1 | |
Loss of personal independence in daily activities, Eczema, Drug ineffective, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 42 | 25134053 |
US |
19 | 2 |
Eczema, Intentional product misuse, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 43 | 25134100 |
US |
44 | 1 |
Dry skin, Paraesthesia, Pruritus, Eczema, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 44 | 25134729 |
US |
38 | 2 |
Eczema, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 45 | 25134891 |
US |
19 | 1 |
Eczema, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 46 | 25134954 |
FR |
78 | 1 |
Eczema, Epistaxis, Intra-abdominal haematoma, |
||||
TOCILIZUMAB, PREDNISONE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, SITAGLIPTIN, RAMIPRIL, PREGABALIN, CYANOCOBALAMIN, FOLIC ACID, LANSOPRAZOLE, POLYETHYLENE GLYCOL (3350), POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL 400, MOMETASONE FUROATE, MOMETASONE, |
||||
| 47 | 25135172 |
US |
1 | |
Eczema, Skin exfoliation, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 48 | 25135378 |
US |
22 | 1 |
Eczema, Pruritus, |
||||
DUPILUMAB, |
||||
| 49 | 25135459 |
CZ |
1 | |
Ileus, Eczema, Eczema, Dermatitis, Rash, |
||||
CEMIPLIMAB-RWLC, |
||||
| 50 | 25135822 |
US |
8 | 1 |
Sleep disorder, Dry skin, Memory impairment, Eczema, Therapeutic response decreased, Eosinophilic oesophagitis, Product dose omission in error, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, GABAPENTIN, |
||||
| 51 | 25136065 |
CA |
56 | 2 |
Eczema, COVID-19, Hypersensitivity, Off label use, |
||||
INFLIXIMAB, INFLIXIMAB, CYANOCOBALAMIN, |
||||
| 52 | 25136284 |
US |
29 | 2 |
Eczema, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 53 | 25136330 |
US |
74 | 1 |
Dermatitis atopic, Eczema, Rash pruritic, |
||||
DUPILUMAB, |
||||
| 54 | 25126311 |
US |
70 | 2 |
Eczema, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, MACITENTAN, TREPROSTINIL, SOTATERCEPT-CSRK, |
||||
| 55 | 25126382 |
US |
57 | 1 |
Eczema, |
||||
DUPILUMAB, |
||||
| 56 | 25126784 |
US |
2 | |
Eczema, |
||||
BIMEKIZUMAB, ADALIMUMAB, |
||||
| 57 | 25127077 |
US |
21 | 2 |
Psoriasis, Eczema, |
||||
BIMEKIZUMAB, |
||||
| 58 | 25127826 |
CA |
42 | 2 |
Blister, Brain fog, Cerebral disorder, Depression, Dry skin, Eczema, Fatigue, Gastrointestinal disorder, Necrotising fasciitis streptococcal, Psoriasis, Pustule, Rash, Skin exfoliation, Urticaria, |
||||
VEDOLIZUMAB, ADALIMUMAB, UPADACITINIB, USTEKINUMAB, |
||||
| 59 | 25128776 |
US |
14 | 2 |
Eczema, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 60 | 25128981 |
US |
73 | 1 |
Pruritus, Eczema, |
||||
DUPILUMAB, ERGOCALCIFEROL, LUTEIN, VITAMIN C, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ATORVASTATIN CALCIUM, CARVEDILOL, EMPAGLIFLOZIN AND LINAGLIPTIN, RAMIPRIL, |
||||
| 61 | 25128997 |
US |
48 | 1 |
Eczema, |
||||
DUPILUMAB, |
||||
| 62 | 25129137 |
US |
32 | 1 |
Eczema, |
||||
DUPILUMAB, |
||||
| 63 | 25129182 |
US |
11 | 1 |
Eczema, Erythema, Rash, |
||||
DUPILUMAB, |
||||
| 64 | 25129289 |
US |
5 | 1 |
Anxiety, Eczema, Therapeutic response decreased, |
||||
DUPILUMAB, |
||||
| 65 | 25129305 |
US |
47 | 1 |
Eczema, Swelling, Urticaria, Pruritus, Injection site pain, Condition aggravated, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 66 | 25129410 |
US |
26 | 2 |
Rebound eczema, Eczema, Incorrect dose administered, Inappropriate schedule of product administration, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 67 | 25129809 |
US |
48 | 1 |
Eczema, Injection site pain, |
||||
DUPILUMAB, |
||||
| 68 | 25129862 |
US |
52 | 2 |
Eczema, |
||||
DUPILUMAB, |
||||
| 69 | 25129973 |
US |
47 | 1 |
Eczema, Erythema, Dry skin, Pruritus, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 70 | 25129996 |
US |
2 | |
Eczema, |
||||
DUPILUMAB, METHENAMINE HIPPURATE, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, BENZTROPINE MESYLATE, BENZTROPINE, PROGESTERONE, TROSPIUM CHLORIDE, DULOXETINE HYDROCHLORIDE, DULOXETIN HYDROCHLORIDE, DULOXETINE, VIBEGRON, BUPROPION HYDROCHLORIDE, BUPROPION, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, |
||||
| 71 | 25130625 |
BR |
66 | 1 |
Chronic coronary syndrome, Cellulitis, Blood creatine phosphokinase increased, Eczema, Coronary artery disease, Neoplasm, Dyslipidaemia, Urticaria chronic, Blood cholesterol abnormal, Illness, Sciatica, Back pain, Feeling abnormal, |
||||
RANIBIZUMAB, SIMVASTATIN, SIMVASTATIN, PAZOPANIB HYDROCHLORIDE, INCLISIRAN, INCLISIRAN, INCLISIRAN, |
||||
| 72 | 25130724 |
FR |
53 | 2 |
Feeling abnormal, Retinal vein occlusion, Anaemia, Road traffic accident, Fall, Craniocerebral injury, Vertigo, Cervical vertebral fracture, Back disorder, Hand dermatitis, Deafness, Dyspnoea, Fatigue, Dizziness, Chest pain, Influenza, Fear of falling, Tachycardia, Pain in extremity, Fear, Polyuria, Mouth ulceration, Dry mouth, Lip injury, Serum ferritin decreased, Eczema, Drug ineffective, Drug intolerance, Inappropriate schedule of product administration, |
||||
SPIRONOLACTONE, |
||||
| 73 | 25130883 |
US |
6 | 1 |
Eczema, Injection site erythema, Injection site swelling, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 74 | 25130980 |
NL |
2 | |
Respiratory tract infection, Drug ineffective, Eczema, Drug hypersensitivity, Asthma, Nausea, Erythema, Stridor, Dyspnoea, Tachypnoea, |
||||
TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, METHYLPREDNISOLONE, RITUXIMAB, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, PREDNISONE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, |
||||
| 75 | 25132031 |
US |
45 | 1 |
Eczema, Inappropriate schedule of product administration, |
||||
DUPILUMAB, |
||||
| 76 | 25121197 |
US |
23 | 2 |
Eczema, Dry skin, Pruritus, Skin exfoliation, |
||||
DUPILUMAB, |
||||
| 77 | 25121248 |
US |
37 | 1 |
Eczema, Erythema, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 78 | 25121283 |
US |
1 | |
Eczema, Inappropriate schedule of product administration, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 79 | 25121310 |
US |
1 | |
Eczema, |
||||
DUPILUMAB, |
||||
| 80 | 25121436 |
US |
2 | |
Eczema, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 81 | 25121997 |
FR |
||
Toxic skin eruption, Eczema, Erysipelas, |
||||
ACALABRUTINIB, |
||||
| 82 | 25123173 |
US |
51 | 2 |
Eczema, Arthralgia, Eosinophilic oesophagitis, |
||||
DUPILUMAB, |
||||
| 83 | 25123288 |
US |
52 | 2 |
Eczema, Rash, Pruritus, Sleep disorder due to a general medical condition, Affective disorder, |
||||
DUPILUMAB, |
||||
| 84 | 25123301 |
US |
28 | 2 |
Eczema, Erythema, Periorbital swelling, Pruritus, Dry skin, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 85 | 25123303 |
US |
48 | 1 |
Eczema, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 86 | 25123356 |
US |
2 | 1 |
Eczema, |
||||
DUPILUMAB, |
||||
| 87 | 25123427 |
RU |
8 | |
Eczema nummular, Dry skin, Eczema, Rash papular, Rash erythematous, |
||||
SELUMETINIB, |
||||
| 88 | 25123869 |
FR |
3 | |
Respiratory syncytial virus bronchiolitis, Respiratory distress, Nasal congestion, Cough, Poor feeding infant, Tachypnoea, Rales, Wheezing, Eczema, Asthenia, Drug ineffective, |
||||
NIRSEVIMAB, |
||||
| 89 | 25124056 |
US |
35 | 2 |
Eczema, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 90 | 25124093 |
US |
2 | |
Eczema, Off label use, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 91 | 25124428 |
US |
||
Eczema, |
||||
LEBRIKIZUMAB-LBKZ, |
||||
| 92 | 25124822 |
DE |
29 | 2 |
Eczema, |
||||
DIROXIMEL FUMARATE, |
||||
| 93 | 25125053 |
US |
12 | 2 |
Pain, Eczema, Skin lesion, |
||||
DUPILUMAB, |
||||
| 94 | 25125068 |
DE |
2 | |
Gastrointestinal fungal infection, Candida infection, Headache, Dizziness, Anal pruritus, Frequent bowel movements, Asthenia, Eczema, |
||||
LEVONORGESTREL, |
||||
| 95 | 25125234 |
US |
2 | |
Eczema, |
||||
DUPILUMAB, |
||||
| 96 | 25125417 |
US |
27 | 2 |
Eczema, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 97 | 25125454 |
GB |
||
Tuberculosis, Crohn^s disease, Eczema, Arthralgia, |
||||
| 98 | 25125455 |
US |
33 | 2 |
Eczema, |
||||
DUPILUMAB, DUPILUMAB, TRALOKINUMAB-LDRM, |
||||
| 99 | 25125712 |
US |
16 | 2 |
Eczema, Rash, Injection site pain, Product dose omission in error, Inappropriate schedule of product administration, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 100 | 25126040 |
US |
53 | 1 |
Eczema, |
||||
DUPILUMAB, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28